cardiovascular-agents and Muscular-Atrophy

cardiovascular-agents has been researched along with Muscular-Atrophy* in 1 studies

Reviews

1 review(s) available for cardiovascular-agents and Muscular-Atrophy

ArticleYear
Comorbidities and systemic effects of chronic obstructive pulmonary disease.
    Clinics in chest medicine, 2014, Volume: 35, Issue:1

    Although primarily a lung disease, chronic obstructive pulmonary disease (COPD) is now recognized to have extrapulmonary effects on distal organs, the so-called systemic effects and comorbidities of COPD. Skeletal muscle dysfunction, nutritional abnormalities including weight loss, cardiovascular complications, metabolic complications, and osteoporosis, among others, are all well-recognized associations in COPD. These extrapulmonary effects add to the burden of mortality and morbidity in COPD and therefore should be actively looked for, assessed, and treated.

    Topics: Anemia; Cardiovascular Agents; Cardiovascular Diseases; Humans; Lung Neoplasms; Muscular Atrophy; Osteoporosis; Pulmonary Disease, Chronic Obstructive

2014